Jolien Tol

JoinMap® 4, Software for the calculation of genetic linkage maps in experimental populations

J. Van Ooijen, J. Van Ooijen, JW van 't Verlaat et al. · 2006 · 1.6K citations

Life Sciences, Biology, Genetics +15

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +16

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Lieke H. J. Simkens, Harm van Tinteren, Anne M. May et al. · The Lancet · 2015 · 528 citations

Medicine, Oncology, Pharmacology +13

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab

Jolien Tol, Jeroen R. Dijkstra, Marjolein Klomp et al. · European Journal of Cancer · 2010 · 216 citations

Medicine, Oncology, Pharmacology +14

Relationship between Single Nucleotide Polymorphisms and Haplotypes in <i>DPYD</i> and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

Maarten J. Deenen, Jolien Tol, Artur M Burylo et al. · Clinical Cancer Research · 2011 · 183 citations

Medicine, Genetics, Oncology +17